N. Vandegraaff et al., Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: Putative inhibitors of HIV-1 integrase, ANTIM AG CH, 45(9), 2001, pp. 2510-2516
To study the effect of potential human immunodeficiency virus type 1 (HIV-1
) integrase inhibitors during virus replication in cell culture, we used a
modified nested Alu-PCR assay to quantify integrated HIV DNA in combination
with the quantitative analysis of extrachromosomal HIV DNA. The two diketo
acid integrase inhibitors (L-708,906 and L-731,988) blocked the accumulati
on of integrated HIV-1 DNA in T cells following infection but did not alter
levels of newly synthesized extrachromosomal HIV DNA. In contrast, we demo
nstrated that L17 (a member of the bisaroyl hydrazine family of integrase i
nhibitors) and AR177 (an oligonucleotide inhibitor) blocked the HIV replica
tion cycle at, or prior to, reverse transcription, although both drug's inh
ibited integrase activity in cell-free assays. Quercetin dihydrate (a flavo
ne) was shown to not have any antiviral activity in our system despite repo
rted anti-integration properties in cell-free assays. This refined Alu-PCR
assay for HIV provirus is a useful tool for screening anti-integration comp
ounds identified in biochemical assays for their ability to inhibit the acc
umulation of integrated HIV DNA in cell culture, and it may be useful for s
tudying the effects of these inhibitors in clinical trials.